In the initial stages of cancer, the extracts of this fruit can stop the multiplication of cancerous cells and even kill them.
This discovery is the result of cell viability testing that was conducted on colon cancer; a collaborative study led by the Universidad Nacional de Colombia, the Instituto Tecnológico Metropolitano de Medellín (ITM), the Universidad de Antioquia and Colciencias (a government agency that supports research, science and technology in Colombia).
Valentina Ramírez Maldonado is a researcher with a master’s in science and biotechnology from the Medellín branch of the Universidad Nacional; she explains that the lab tests showed that the extract of this fruit’s pulp reduced the efficiency of cloned cancerous cells by up to 16. The expert further explains that when cancer is in its early stages, the fruit’s properties can stop these cells from reproducing in the first phase of the cell’s cycle, “If it doesn’t kill the cells, it prevents them from multiplying,” she states.
“Other studies have already proven the cancer-fighting effects of passionfruit pulp with other types of cancer, such as Walker carcinoma and in acute lymphocytic leukemia cells. But they have never been conducted on colon cancer cells,” the researcher explains.
These results should help new tests continue to identify the properties of passionfruit with the greatest biological activity so they may be analyzed, described and eventually used to treat cancer. “The pulp may have the potential to contribute to the development of therapeutic treatments in the future.”
Colon cancer is the fourth leading cause of cancer-related deaths in the world.